Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.625 USD | -2.78% |
|
-9.83% | +79.73% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.73% | 121M | |
+36.80% | 53.67B | |
+33.81% | 38.86B | |
-8.29% | 38.76B | |
-8.98% | 27.27B | |
+11.70% | 25.91B | |
-15.05% | 20.29B | |
+32.08% | 12.78B | |
+28.36% | 12.18B | |
-1.72% | 11.96B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- HC Wainwright Lowers Cardiff Oncology's Price Target to $22 From $25, Buy Rating Kept